MGP Ingredients, Inc. Earnings Recaps
Q1 2026
Apr 30, 2026
MGP Ingredients shares fell 1.3% following Q1 results, reflecting a neutral market reaction as investors weighed modest EBITDA and EPS outperformance against ongoing topline declines and temporary production idling.
Key takeaways
- Q1 net sales declined to $106.4 million; both adjusted EBITDA ($15 million) and EPS ($0.15) were lower year-over-year but surpassed management's expectations.
- Gross margin improved by 180 basis points to 47.8%, driven by mix and revenue growth management, despite lower overall profit.
- Branded Spirits Premium Plus portfolio saw sales rise 1.5%, with Penelope Bourbon up 10% year-over-year; however, overall branded spirits sales remained down due to private label weakness.
- Temporary idling of Limestone Branch and Lux Row distilleries announced to address elevated inventory levels; core Lawrenceburg facility remains operational.
- Ongoing portfolio rationalization with over 30 low-contribution brands discontinued in Q1 and further cuts planned, representing about 1% of segment sales.
Q3 2025
Oct 29, 2025
MGP Ingredients delivered a strong Q3 2025 performance with robust operating cash flows and an upward revision of full-year profit guidance, despite a 19% decline in consolidated sales primarily due to shifting brand dynamics.
Key takeaways
- Adjusted EBITDA reached $32 million, exceeding expectations, with adjusted EPS at $0.85.
- Year-to-date operating cash flows rose 26% to $93 million.
- Full-year 2025 adjusted EBITDA guidance raised to $110–115 million and adjusted EPS guidance to $2.60–2.75.
- Strategic initiatives underway include focused brand management and operational efficiency enhancements.
- Positive momentum noted in the premium plus portfolio, particularly driven by Penelope Bourbon's strong performance.